Cancer Test Overview videos

BRCA1 and BRCA2 are tumor suppressor genes that have an essential role in both DNA repair and cell cycle control systems. Germline BRCA1 and BRCA2 mutations are implicated in 25-50% of hereditary breast cancer cases.

 

CancerNextTM is a next generation (next-gen) sequencing panel that simultaneously analyzes 28 genes that contribute to increased risk for breast, colon, ovarian, uterine and other cancers.

 

ColoNextTM is a next generation (next-gen) sequencing panel that simultaneously analyzes 14 genes that contribute to increased risk for colon cancer.
 
 

Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is an autosomal dominant syndrome that predisposes to malignancy, including a lifetime colorectal cancer risk of up to 80%.

 

OvaNextTM is a next generation (next-gen) sequencing panel that simultaneously analyzes 23 genes that contribute to increased risk for breast, ovarian and/or uterine cancers.

 



PancNextTM is a next-generation sequencing (NGS) panel that simultaneously analyzes 13 genes implicated in hereditary pancreatic cancer.

 



PGLNextTM is a next-generation sequencing (NGS) panel that simultaneously analyzes 10 genes associated with an increased risk of developing paragangliomas and/or pheochromocytomas(PGL/PCC).

 



RenalNextTM is a next-generation sequencing (NGS) panel that simultaneously analyzes 18 genes implicated in hereditary renal cell carcinoma.